A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare) | |
Zhu J., Sun X., Zhang T., Liu A., Zhu Y., Jia J., Zhu Y., Tan S., Zhou J., Zhang C., Wang X., Cai G., Luo B., Wu J., Yang J., Zhang Z. | |
刊名 | Journal of Clinical Oncology |
2017 | |
卷号 | 35 |
ISSN号 | 0732-183X |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3613102 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Zhu J., Sun X., Zhang T., Liu A., Zhu Y., Jia J., Zhu Y., Tan S., Zhou J., Zhang C., Wang X., Cai G., Luo B., Wu J., Yang J., Zhang Z.. A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare)[J]. Journal of Clinical Oncology,2017,35. |
APA | Zhu J., Sun X., Zhang T., Liu A., Zhu Y., Jia J., Zhu Y., Tan S., Zhou J., Zhang C., Wang X., Cai G., Luo B., Wu J., Yang J., Zhang Z..(2017).A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare).Journal of Clinical Oncology,35. |
MLA | Zhu J., Sun X., Zhang T., Liu A., Zhu Y., Jia J., Zhu Y., Tan S., Zhou J., Zhang C., Wang X., Cai G., Luo B., Wu J., Yang J., Zhang Z.."A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare)".Journal of Clinical Oncology 35(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论